Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Greg Gilman
AddedMar 31, 2024
UpdatedMay 31, 2026
Greg Gilman

Greg Gilman

Co-Founder, Science Blockchain

CrunchbaseLinkedIn

Greg Gilman's Career

Science Blockchain
Science Blockchain

Los Angeles, CA, US

Co-Founder
Protego
Protego

Seattle, WA, US

Board Member· Board
RxVantage
RxVantage

Culver City, CA, US

Board Member· Board
Science
Science

Santa Monica, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Greg Gilman's Career

Science Blockchain
Science Blockchain
Investment FirmInvestment Firm302011Los Angeles, CA, US
Co-Founder

Similar to Science Blockchain

ScienceScienceSanta Monica, CA, USest. 2011ScienceSanta Monica, CA, US · est. 2011

Science partners, developing and funding disruptive tech-based companies.

Investment Firm · $72.3M236
Tally CapitalTally CapitalChicago, IL, USest. 2013Tally CapitalChicago, IL, US · est. 2013

Private investment firm capitalizing on blockchain technology opportunities for entrepreneurs and investors.

Investment Firm6
Block VenturesBlock VenturesLos Angeles, CA, USest. 2013Block VenturesLos Angeles, CA, US · est. 2013

Block Ventures: A global venture capital firm investing in and accelerating blockchain technology companies.

Investment Firm750
Blockchain CoinvestorsBlockchain CoinvestorsTiburon, CA, USest. 2014Blockchain CoinvestorsTiburon, CA, US · est. 2014

Blockchain Coinvestors: Top-ranking investment strategy provider for 750+ blockchain companies globally.

Investment Firm16
Protego
Protego
Investment FirmInvestment Firm$70M862017Seattle, WA, US
Board Member· Board

Leadership at Protego

Ron TotaroRon TotaroCEO

Similar to Protego

Custodia BankCustodia BankCheyenne, WY, USest. 2020Custodia BankCheyenne, WY, US · est. 2020

Custodia Bank: A regulated crypto-asset banking operator and custodian, bridging digital assets to USD.

Investment Firm · $45.5M37
GrayscaleGrayscaleNew York City, NY, USest. 2000GrayscaleNew York City, NY, US · est. 2000

Grayscale: Your digital asset brokerage for easy exposure to digital assets.

Investment Firm9
Copy TradesCopy TradesCarlsbad, CA, USest. 2023Copy TradesCarlsbad, CA, US · est. 2023

Carlsbad-based financial services firm providing trading tools for Chief Investment Officers.

Investment Firm · $100k5
BanklessBanklessBavaria, DEBanklessBavaria, DE

Bankless: Your ultimate crypto finance solution.

Investment Firm5
RxVantage
RxVantage
Series B$2.8M1432008Culver City, CA, US
Board Member· Board

Leadership at RxVantage

Daniel GilmanDaniel GilmanCo-Founder
Jason NazarJason NazarBoard Member

Similar to RxVantage

RxLiveRxLiveSt. Petersburg, FL, USPharmacy, Telehealthest. 2017RxLiveSt. Petersburg, FL, US · est. 2017

RxLive: A nationwide telehealth pharmacy platform for comprehensive medication management.

Angel · $10.5M48
RxWareRxWareBethesda, MD, USPatient Engagementest. 2013RxWareBethesda, MD, US · est. 2013

RxWare.io, a SaaS startup, simplifies patient journeys by connecting healthcare services, optimizing therapy outcomes.

Series A · $10.6M24
Rx.HealthRx.HealthNew York City, NY, USest. 2016Rx.HealthNew York City, NY, US · est. 2016

Rx.Health offers a digital medicine platform for data collection, patient interaction, and streamlined workflows in the US.

Seed · $2.3M28
InStockRxInStockRxCharlotte, NC, USInventory Management, Pharmacy Softwareest. 2020InStockRxCharlotte, NC, US · est. 2020

InStockRx: A cloud-based hub for pharmacies offering inventory management and marketplace services.

Pre-Seed · $120k4
Science
Science
Investment FirmInvestment Firm$72.3M2362011Santa Monica, CA, US
Co-Founder

Recent news

Science Corp. raises $230M as it races to bring its brain implant to marketTechCrunch · 2026

Leadership at Science

Peter PhamPeter PhamCo-Founder
Tom DareTom DareCo-Founder
Michael JonesMichael JonesCo-Founder
Mike MacadaanMike MacadaanCo-Founder

Greg Gilman's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Greg Gilman

Mitchell DannMitchell DannFounder · Sapient Capital ManagementMike MacalusoMike MacalusoCo-Founder · Ampio PharmaceuticalsTom PetroTom PetroBoard Member · UnivestJoe AllegraJoe AllegraBoard Member · Edison PartnersAnthony DavisAnthony DavisFounder · Linden Capital Partners